AT Systematization unit gets nod to market nitrile gloves in US
17 Dec 2021
AT Systematization Bhd (AT) will now be able to proceed with the marketing activities of its nitrile gloves in the US, after meeting the Food and Drug Administration’s (FDA) procedural requirements.
This will be done via its wholly-owned subsidiary, AT Glove Engineering Sdn Bhd (ATGESB).
AT received a notification letter dated Dec 16, 2021 from the FDA relating to the pre-market notification clearance, which potentially paves the way for the company to ship and market its products in that country.
“The FDA 510(k) Medical Product Licence clearance allows us to expand our product reach to a broader market into the highly lucrative US market.
“It is part of our efforts to expand the company’s geographical reach,” said AT managing director Choong Lee Aun in a statement on Friday (Dec 17).
The US expansion will also take up additional production capacity coming onstream. Four lines will be commissioned soon at the group’s Chemor, Perak factory, which will boost production capacity to two billion pieces per year, said Choong.
AT started production in 2020 and is currently running six lines with an annual capacity of 1.2 billion pieces in its Chemor factory. The company is also aggressively ramping up capacity expansion for the glove division to capture more business.
It recently completed the acquisition of several industrial plots in Kamunting, Perak to cater for over 50 production lines in order to boost capacity.
Glove demand is expected to continue to rise due to better healthcare awareness, especially from the emerging economies, Choong said.
“There is increasing usage of gloves in more sectors and industries as part of the new normal, including airlines, hospitality, and the food processing sector. The rising need for quality medical gloves will continue to sustain the global demand for gloves in the long run,” he said.